Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. uri icon

authors

  • Kaur, Amandeep
  • McNerney, Megan E
  • Wu, Leo P
  • Akmatbekov, Aibek
  • Segal, Jeremy
  • Tjota, Melissa Y
  • Gurbuxani, Sandeep
  • Cheng, Jason X
  • Yeon, Su-Yeon
  • Ravisankar, Harini V
  • Fitzpatrick, Carrie
  • Rojek, Alexandra E
  • Lager, Angela
  • Drazer, Michael W
  • Saygin, Caner
  • Wanjari, Pankhuri
  • Katsonis, Panagiotis
  • Lichtarge, Olivier
  • Churpek, Jane E
  • Ghosh, Sharmila B
  • Patel, Ami B
  • Menon, Madhu P
  • Symes, Emily
  • Arber, Daniel A
  • Wang, Peng
  • Venkataraman, Girish
  • Mariam Nawas, MD
  • Patel, Anand A
  • Patel, Jay L
  • Sojitra, Payal
  • Aqil, Barina
  • Sukhanova, Madina

publication date

  • June 18, 2024